These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 34673330)

  • 1. Lumefantrine attenuates Plasmodium falciparum artemisinin resistance during the early ring stage.
    Kümpornsin K; Loesbanluechai D; de Cozar C; Kotanan N; Chotivanich K; White NJ; Wilairat P; Gomez-Lorenzo MG; Gamo FJ; Sanz LM; Lee MCS; Chookajorn T
    Int J Parasitol Drugs Drug Resist; 2021 Dec; 17():186-190. PubMed ID: 34673330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local emergence in Amazonia of
    Mathieu LC; Cox H; Early AM; Mok S; Lazrek Y; Paquet JC; Ade MP; Lucchi NW; Grant Q; Udhayakumar V; Alexandre JS; Demar M; Ringwald P; Neafsey DE; Fidock DA; Musset L
    Elife; 2020 May; 9():. PubMed ID: 32394893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment Failure in a UK Malaria Patient Harboring Genetically Variant Plasmodium falciparum From Uganda With Reduced In Vitro Susceptibility to Artemisinin and Lumefantrine.
    van Schalkwyk DA; Pratt S; Nolder D; Stewart LB; Liddy H; Muwanguzi-Karugaba J; Beshir KB; Britten D; Victory E; Rogers C; Millard J; Brown M; Nabarro LE; Taylor A; Young BC; Chiodini PL; Sutherland CJ
    Clin Infect Dis; 2024 Feb; 78(2):445-452. PubMed ID: 38019958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artemisinin Resistance and Stage Dependency of Parasite Clearance in Falciparum Malaria.
    Intharabut B; Kingston HW; Srinamon K; Ashley EA; Imwong M; Dhorda M; Woodrow C; Stepniewska K; Silamut K; Day NPJ; Dondorp AM; White NJ;
    J Infect Dis; 2019 Apr; 219(9):1483-1489. PubMed ID: 30657916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naturally Acquired Kelch13 Mutations in Plasmodium falciparum Strains Modulate
    Duffy S; Avery VM
    Microbiol Spectr; 2022 Oct; 10(5):e0128221. PubMed ID: 36094220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artemisinin Action and Resistance in Plasmodium falciparum.
    Tilley L; Straimer J; Gnädig NF; Ralph SA; Fidock DA
    Trends Parasitol; 2016 Sep; 32(9):682-696. PubMed ID: 27289273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of kelch13 artemisinin resistance markers but strong selection for lumefantrine-tolerance molecular markers following 18 years of artemisinin-based combination therapy use in Mpumalanga Province, South Africa (2001-2018).
    Raman J; Kagoro FM; Mabuza A; Malatje G; Reid A; Frean J; Barnes KI
    Malar J; 2019 Aug; 18(1):280. PubMed ID: 31438951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmodium berghei K13 Mutations Mediate
    Simwela NV; Stokes BH; Aghabi D; Bogyo M; Fidock DA; Waters AP
    mBio; 2020 Nov; 11(6):. PubMed ID: 33173001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viability Screen of LOPAC
    Tong JX; Ang SEL; Tan EHN; Tan KSW
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30718250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerance of Gambian Plasmodium falciparum to Dihydroartemisinin and Lumefantrine Detected by
    Mbye H; Bojang F; Jawara AS; Njie B; Mohammed NI; Okebe J; D'Alessandro U; Amambua-Ngwa A
    Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33020162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine.
    Venkatesan M; Gadalla NB; Stepniewska K; Dahal P; Nsanzabana C; Moriera C; Price RN; Mårtensson A; Rosenthal PJ; Dorsey G; Sutherland CJ; Guérin P; Davis TME; Ménard D; Adam I; Ademowo G; Arze C; Baliraine FN; Berens-Riha N; Björkman A; Borrmann S; Checchi F; Desai M; Dhorda M; Djimdé AA; El-Sayed BB; Eshetu T; Eyase F; Falade C; Faucher JF; Fröberg G; Grivoyannis A; Hamour S; Houzé S; Johnson J; Kamugisha E; Kariuki S; Kiechel JR; Kironde F; Kofoed PE; LeBras J; Malmberg M; Mwai L; Ngasala B; Nosten F; Nsobya SL; Nzila A; Oguike M; Otienoburu SD; Ogutu B; Ouédraogo JB; Piola P; Rombo L; Schramm B; Somé AF; Thwing J; Ursing J; Wong RPM; Zeynudin A; Zongo I; Plowe CV; Sibley CH; Asaq Molecular Marker Study Group
    Am J Trop Med Hyg; 2014 Oct; 91(4):833-843. PubMed ID: 25048375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The emerging threat of artemisinin resistance in malaria: focus on artemether-lumefantrine.
    Djimde AA; Makanga M; Kuhen K; Hamed K
    Expert Rev Anti Infect Ther; 2015 Aug; 13(8):1031-45. PubMed ID: 26081265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative stress changes the effectiveness of artemisinin in
    Pires CV; Cassandra D; Xu S; Laleu B; Burrows JN; Adams JH
    mBio; 2024 Mar; 15(3):e0316923. PubMed ID: 38323831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel polymorphisms in Plasmodium falciparum ABC transporter genes are associated with major ACT antimalarial drug resistance.
    Veiga MI; Ferreira PE; Jörnhagen L; Malmberg M; Kone A; Schmidt BA; Petzold M; Björkman A; Nosten F; Gil JP
    PLoS One; 2011; 6(5):e20212. PubMed ID: 21633513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baseline in vivo, ex vivo and molecular responses of Plasmodium falciparum to artemether and lumefantrine in three endemic zones for malaria in Colombia.
    Aponte S; Guerra ÁP; Álvarez-Larrotta C; Bernal SD; Restrepo C; González C; Yasnot MF; Knudson-Ospina A
    Trans R Soc Trop Med Hyg; 2017 Feb; 111(2):71-80. PubMed ID: 28460112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of association between polymorphisms in the K13 gene and the presence of Plasmodium falciparum parasites at day 3 after treatment with artemisinin derivatives in Senegal.
    Madamet M; Kounta MB; Wade KA; Lo G; Diawara S; Fall M; Bercion R; Nakoulima A; Fall KB; Benoit N; Gueye MW; Fall B; Diatta B; Pradines B
    Int J Antimicrob Agents; 2017 Jun; 49(6):754-756. PubMed ID: 28450175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in Liberia.
    Otienoburu SD; Maïga-Ascofaré O; Schramm B; Jullien V; Jones JJ; Zolia YM; Houzé P; Ashley EA; Kiechel JR; Guérin PJ; Le Bras J; Houzé S
    Malar J; 2016 Sep; 15(1):452. PubMed ID: 27596849
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Straimer J; Gnädig NF; Stokes BH; Ehrenberger M; Crane AA; Fidock DA
    mBio; 2017 Apr; 8(2):. PubMed ID: 28400526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of Artemisinin-Resistant Malaria in Africa.
    Balikagala B; Fukuda N; Ikeda M; Katuro OT; Tachibana SI; Yamauchi M; Opio W; Emoto S; Anywar DA; Kimura E; Palacpac NMQ; Odongo-Aginya EI; Ogwang M; Horii T; Mita T
    N Engl J Med; 2021 Sep; 385(13):1163-1171. PubMed ID: 34551228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo selection of Plasmodium falciparum parasites carrying the chloroquine-susceptible pfcrt K76 allele after treatment with artemether-lumefantrine in Africa.
    Sisowath C; Petersen I; Veiga MI; Mårtensson A; Premji Z; Björkman A; Fidock DA; Gil JP
    J Infect Dis; 2009 Mar; 199(5):750-7. PubMed ID: 19210165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.